ensidipine bangladesh version

Ensidipine (enasidenib) is a drug for the treatment of acute myeloid leukemia. It is a targeted drug targeting specific IDH2 mutations. Ensidipine is an optimistic treatment option for AML patients.

Encidipine was approved for marketing by Nikkei in 20178month1 and has not yet been launched in China. Ensidipine has both original and generic drugs. The original drug is available in the United States. The price in pharmacies is 100mg30 tablets300,000 yuan. It is expensive and difficult for ordinary families to afford. The generic drugs that are officially on the market are available in Bangladesh. The retail price of Ziska Pharmaceuticals in Bangladesh is 50mg60 Tablets4Around 1,000 yuan, the retail price of Bangladesh Everest Pharmaceuticals50mg30tablets5Around 1,000 yuan, both versions are officially on the market, have government approval, and the quality of the drugs is guaranteed. Patients can choose the drug version according to their own economic situation. In addition, Lucius Pharmaceuticals of Laos is also producing and has been put on the market. The retail price of the pharmaceutical factory is about 50mg 30 tablets 2 about one thousand yuan.

Differentiation syndrome with or without leukocytosis may occur while taking ensidipine, which may be life-threatening or fatal in severe cases. If signs or symptoms suggestive of this syndrome occur, initiate corticosteroid therapy and monitor hemodynamic parameters until symptoms improve. Interrupt treatment if severe pulmonary symptoms requiring respiratory support (i.e., intubation, assisted breathing) occur or if renal insufficiency persists for more than 48 hours despite corticosteroid therapy. If pulmonary or renal manifestations occur, close monitoring in the hospital is recommended. If you want to get more high-quality information, you can contact YaDE. YaDE will do its best to learn more about high-quality overseas drugs for you.